Skip to main content

Table 2 Antimicrobial resistance of K. pneumoniae ESBL-producing isolates

From: High clonal diversity of ESBL-producing Klebsiella pneumoniae isolates from clinical samples in a non-outbreak situation. A cohort study

Antibiotic

Community- acquired (N = 5)

Healthcare- related N = 24

Hospital- acquired infection (N = 31)

Total

Amoxicillin-clavulanic acid

3/5

21/24

31/31

55/60

Amikacin

0/5

2/24

1/27

3/57

Cefepime

5/5

24/24

31/31

60/60

Cefuroxime

5/5

24/24

31/31

60/60

Cefotaxime

5/5

24/24

31/31

60/60

Ceftazidime

5/5

24/24

31/31

60/60

Ciprofloxacin

3/5

21/24

31/31

55/60

Ertapenem

0/5

0/24

0/31

0 / 60

Gentamicin

1/5

13/24

14/31

28 /60

Imipenem

0/5

0/24

0 /31

0 /60

Piperacillin/tazobactam

2/5

12/24

20/31

34/60

Trimethoprim/sulfamethoxazole

3/5

21/24

29/31

53/60